VSee Health, Inc. (VSEE) Stock Forecast & Price Target
VSee Health, Inc. · NASDAQ
$0.02-0.00 (-4.17%)
15-min delayed · Aug 25, 3:15 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering VSee Health, Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $5.00 to $5.00, so the covering firms are broadly aligned. The average target of $5.00 sits 21639% above the current $0.02. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.12 next quarter toward $-0.36 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to VSee Health, Inc.
12-MONTH PRICE TARGET
$5.00
+21639.1% upside
Average analyst target vs $0.02 current
Highest Target$5.00
Average Target$5.00
Lowest Target$5.00
VSEE analyst recommendation trends
86420
Aug
Sep
Oct
Nov
Dec
Jan
Strong BuyBuyHoldSellStrong Sell
RATING
AUG
SEP
OCT
NOV
DEC
JAN
Strong Buy
0
0
0
0
0
0
Buy
1
1
1
1
1
1
Hold
0
0
0
0
0
0
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
1
1
1
1
1
1
As of Jan, 1 of 1 firms rate VSEE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
VSEE EPS & revenue forecast
EPS · NEXT QUARTER
$-0.12
Range $-0.12 – $-0.12 · 1 analysts
Next period, 1 analysts expect VSee Health, Inc. to earn $-0.12 a share (range $-0.12 – $-0.12), versus — a year earlier. , growing to $-0.36 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 1 analysts
Revenue is expected to reach — (range — – —).
Top analysts covering VSee Health, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on VSEE.
#1
Allen Klee
Maxim Group · Rank #439
Buy
$5.00+21639.1% to target
Overall win rate
18%
+ Follow
VSEE stock forecast FAQ
Is VSEE stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover VSEE?+
1 analysts have an active rating on VSee Health, Inc..
Who is the most accurate analyst covering VSEE?+
Among analysts who currently cover VSEE, Allen Klee of Maxim Group has the strongest overall Quantellect track record (Rank #439). Their current call is Buy with a $5.00 target.
What is VSee Health, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.12 per share (range $-0.12 – $-0.12) across 1 analysts, rising to $-0.36 the following year.
How much revenue is VSee Health, Inc. expected to report next quarter?+
Consensus revenue is — (range — – —), growing to — next year.
Have analysts been upgrading or downgrading VSEE lately?+
As of Jan, 1 of 1 firms rate VSEE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their VSEE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
